Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • moriah
    Member
    • Dec 2010
    • 23

    #1

    miRNA proportion in mir-seq

    Hi All,

    I received an Illumina HiSeq output on human mirna-seq and after trimming the adapters and alignment to the genome I realized that only 30% of my reads align to miRNAs while other 70% are tRNA,rRNA and other small RNAs.

    I was wondering whether this miRNA proportion is normal?

    Thanks!
  • Nicolas
    Member
    • Apr 2009
    • 41

    #2
    Hi,

    Did you collapse identical sequences (you should not...)? How did you size-selected your RNA? Which tissues is it from (piRNA are abundant in the germline)?

    Comment

    • moriah
      Member
      • Dec 2010
      • 23

      #3
      No, I didn't collapse and it is from breast tissue (tumor and normal).

      Size selection? What do you mean?
      If you mean the library preparation from total RNA, I don't know.

      Thanks!

      Comment

      • Nicolas
        Member
        • Apr 2009
        • 41

        #4
        The protocol for smallRNA-Seq is not the same as for "classical" RNA-Seq, with the aim of purifying the sample from long RNA and enriching for "smallRNA". At one point, we do run a gel and select for the appropriate size (that might be fly-specific, because there is a very abundant 30nt rRNA in Drosophila).

        Other users' input would be useful here!

        Comment

        • moriah
          Member
          • Dec 2010
          • 23

          #5
          Yes, the protocol for small RNA library preparation was followed. The small RNA where isolated for sure and sequenced. But this low proportion of miRNA in my data is what I am not sure about, is it normal? and if not, where can be the problem?

          Thank you

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 11:13 AM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, Yesterday, 10:48 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          35 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Working...